These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9748685)

  • 1. Treatment of erectile dysfunction by an external ischiocavernous muscle stimulator.
    Derouet H; Nolden W; Jost WH; Osterhage J; Eckert RE; Ziegler M
    Eur Urol; 1998 Oct; 34(4):355-9. PubMed ID: 9748685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostaglandin E1 with phentolamine for the treatment of erectile dysfunction.
    Meinhardt W; de la Fuente RB; Lycklama à Nijeholt AA; Vermeij P; Zwartendijk J
    Int J Impot Res; 1996 Mar; 8(1):5-7. PubMed ID: 8735187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prostaglandin E1 in erectile dysfunction].
    Porst H
    Urologe A; 1989 Mar; 28(2):94-8. PubMed ID: 2655258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transurethral alprostadil as therapy for patients who withdrew from or failed prior intracavernous injection therapy.
    Engel JD; McVary KT
    Urology; 1998 May; 51(5):687-92. PubMed ID: 9610580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Current role of intracavernous therapy in the treatment of erectile dysfunction].
    Asuar Aydillo S
    Arch Esp Urol; 2002 Jun; 55(5):475-82. PubMed ID: 12174413
    [No Abstract]   [Full Text] [Related]  

  • 6. [Action of vasoactive drugs in male sexual impotence].
    Morales JC; Elizondo B
    Arch Esp Urol; 1989; 42(9):900-4. PubMed ID: 2624491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Classification of sexual dysfunction for management of intracavernous medication-induced erections.
    Fein RL
    J Urol; 1990 Feb; 143(2):298-301. PubMed ID: 1688954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of transanal pelvic plexus stimulation on penile erection: clinical implications.
    Kayigil O; Agras K; Gurdal M; Serefoglu EC; Okulu E; Ucgul Y
    Int Urol Nephrol; 2007; 39(4):1195-201. PubMed ID: 17505909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Intracavernous pharmacotherapy for treatment and evaluation of impotence].
    Vardi Y; Lidgi S; Moskovitz B; Levin RD
    Harefuah; 1991 Oct; 121(7-8):223-5. PubMed ID: 1783307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determinants of satisfactory rigidity after intracavernosal injection with prostaglandin E1 in men with erectile failure.
    Purvis K; Brekke I; Christiansen E
    Int J Impot Res; 1996 Mar; 8(1):9-16. PubMed ID: 8735188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Response to intracavernous administration of 3 different drugs in the same group of patients with erectile dysfunction].
    Ribé N; Rajmil O; Bassas L; Jurado C; Pomerol JM
    Arch Esp Urol; 2001 May; 54(4):355-9. PubMed ID: 11455770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracavernosal papaverine and phentolamine for the medical management of erectile dysfunction in a genitourinary clinic.
    Armstrong DK; Convery A; Dinsmore WW
    Int J STD AIDS; 1993; 4(4):214-6. PubMed ID: 8399501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Penile response to intracavernosal vasoactive intestinal polypeptide alone and in combination with other vasoactive agents.
    Kiely EA; Bloom SR; Williams G
    Br J Urol; 1989 Aug; 64(2):191-4. PubMed ID: 2765789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracavernous self-injection for erectile failure.
    Ruutu M; Lindström BL; Virtanen J; Alfthan O
    Eur Urol; 1988; 15(1-2):96-8. PubMed ID: 3215245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic and therapeutic technology assessment. Vasoactive intracavernous pharmacotherapy for impotence: papaverine and phentolamine.
    JAMA; 1990 Aug; 264(6):752-4. PubMed ID: 2374280
    [No Abstract]   [Full Text] [Related]  

  • 16. [Evaluation of 452 patients with erectile dysfunction treated by combinations of vasoactive agents by penile injection].
    Segenreich E; Israilov S; Shmueli J; Simon D; Baniel J; Livne P
    Harefuah; 1998 May; 134(9):673-8, 750. PubMed ID: 10909609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracavernous pharmacotherapy for management of erectile dysfunction in spinal cord injury.
    Lloyd LK; Richards JS
    Paraplegia; 1989 Dec; 27(6):457-64. PubMed ID: 2608299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A clinical comparative study on effects of intracavernous injection of sodium nitroprusside and papaverine/phentolamine in erectile dysfunction patients.
    Fu Q; Yao DH; Jiang YQ
    Asian J Androl; 2000 Dec; 2(4):301-3. PubMed ID: 11202421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracavernous injections for impotence.
    Med Lett Drugs Ther; 1987 Oct; 29(751):95-6. PubMed ID: 3670212
    [No Abstract]   [Full Text] [Related]  

  • 20. [Intracavernous injection of vasoactive drugs for treating erectile impotence].
    Yasumoto R; Asakawa M; Kawashima H; Yoshimura R; Maekawa T; Kashiwara N; Tanaka H; Nishio S
    Hinyokika Kiyo; 1988 Feb; 34(2):301-4. PubMed ID: 2454019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.